期刊文献+

西罗莫司滴眼液在兔眼房水内的药动学 被引量:3

Pharmacokinetics of sirolimus in ocular aqueous humors of rabbit
原文传递
导出
摘要 目的探讨西罗莫司滴眼液单次滴兔眼后在房水中的药动学特征。方法 40只新西兰大白兔,局部滴入西罗莫司滴眼液50μL,采用高效液相色谱法测定兔眼房水中西罗莫司的药物浓度,用DAS1.0软件计算药动学参数。结果给药后0~120 h,西罗莫司在兔眼房水中的ρ_(max)为(84.92±37.04)μg·mL^(-1)(-1),t_(1/2)为(43.28±18.11)h,AUC_(0-6)为(1 747.44±571.36)μg·h·mL^(-1),AUC_(0-∞)为(2 335.25±702.42)μg·h·mL^(-1)。空白房水不干扰西罗莫司的含量测定。结论单次滴眼后西罗莫司可以快速穿透眼组织到达前房,并在房水中达到较高的药物浓度。 AIM To study pharmacokinetics of sirolimus in ocular aqueous humors of rabbit after ocular instillation. METHODS Forty New England rabbits were topically applied sirolimus eye drops 50 μL. Ocular aqueous humors were sampled at different intervals after drug instillation, and the drug levels were assayed by HPLC. The pharmacokinetics parameters were analyzed with DAS 1.0 software. RESULTS The peak concen- tration of sirolimus in aqueous humors was (84.92 ± 37.04) μg·mL-1, The half-lives of elimination was (43.28 ±18.11) h. The AUC0-6 was (1 747.44 ± 571.36) μg·h·mL^-1 and AUC0-∞ was (2 335.25 ±702.42)μg·h·mL^-1. Blank aqueous humors did not interfere with the determination of sirolimus. CONCLUSION Sirolimus could rapidly achieve a high concentration in aqueous humor after a single use of sirolimus eye drops in rabbit.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2012年第8期469-472,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 西罗莫司 滴眼液 房水 药动学 sirolimus eye drops rabbits tissue distribution pharmacokinetics
  • 相关文献

参考文献5

  • 1朱曼,郭代红.新型大环内酯类免疫抑制剂-西罗莫司[J].中国药物应用与监测,2005,2(6):26-28. 被引量:22
  • 2缪丽燕,黄晨蓉,曹剑波,钱美英.肾移植病人西罗莫司血药浓度/剂量比与CYP3A5基因多态性的关系[J].中国新药与临床杂志,2007,26(7):524-527. 被引量:8
  • 3CHATEL MA, LARKIN DF. Sirolimus and mycophenolate ascombination prophylaxis in corneal transplant recipients at high rejection risk[J]. Am J Ophthalmol, 2010, 150(2) : 179-184.
  • 4DUGEL PU, BLUMENKRANZ MS, HALLER JA, et al. A randomized, dose-escalation study of subconjunctival and intra- vitreal injections of sirolimus in patients with diabetic macular edema[J]. Ophthalmology, 2012, 119(1) : 124-131.
  • 5YAN ZC, BAI YJ, TIAN Z, et al. Anti-proliferation effects of sirolimus sustained delivery film in rabbit glaucoma filtration surgery[J]. Molecular Vision, 2011, 17: 2495-2506.

二级参考文献28

  • 1王征,樊嘉.雷帕霉素在器官移植中的研究进展[J].国外医学(移植与血液净化分册),2004,2(5):33-35. 被引量:5
  • 2王长希,尚文俊,陈立中,费继光,任斌,黎曙霞,郑克立,唐孝达,范昱,闵志廉,齐隽,黎磊石,刘志红,季曙明.肾移植受者应用西罗莫司治疗窗的临床研究[J].中国新药与临床杂志,2005,24(1):41-45. 被引量:21
  • 3胡永芳,周宏灏.CYP3A4,CYP3A5和MDR1基因多态性对环孢素处置的影响[J].中国药理学通报,2005,21(3):257-261. 被引量:34
  • 4[4]Chung J,Kuo CJ,Crabtree GR,et al.Rapamyein-FkBP specifically blocks growth dependent activation of and signaling by the 70 kd s6 protein kinases[J].Cell,1992,69:1227.
  • 5[5]Dumont FJ,Su O.Mechanism of action of the immunosup-pres sant rapamycin[J].Life Sci,1996,58:373.
  • 6[7]Zimmerman JJ,Kahan BD.Pharmacokinetics of sirolimus in sta ble renal transplant patients after multiple oral dose adminis tration[J].J Clin Pharmacol,1997,37:405.
  • 7[8]Ferron GM,Mishina EV,Zimerman JJ,et al.Population pharma cokinetics of sirolimus in kidney transplant patients[J].Clin Pharmacol Ther,1997,61:416.
  • 8[15]Yatscoff RW,Wang P,Chan K,et al.Rapamycin:distribution,pharmacokinetics,and therapeutic range investigations[J].Ther Drug Monit,1995,17 (6):666.
  • 9[16]Kahan BD,Podbielski J,Napoli KL,et al.Immunosuppressive ef fects and safety of a sirolimus/cyclosporine combination regi men for renal transplantation[J].Transplantation,1998,66 (8):1040.
  • 10[19]Brattstorm C,Wiliczek H,Tyden G,et al.Hyperlipidermia in re nal transplant recipients treated with rapamycin[J].Transplanta tion,1998,65 (9):1272.

共引文献27

同被引文献44

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部